You are here: Industry Insights > Abbott

News List

Abbott initiates groundbreaking study to treat CAD biospectrumasia
April 16, 2018
Trial will assess if stent procedures guided by high-resolution imaging result in larger vessel diameters and improved patient clinical outcomes versus stent procedures that use standard-of-care imaging
Abbott Initiates Groundbreaking Study to Assess Superiority of High-Resolution Imaging Versus Standard-of-Care Angiography in Treating Coronary Artery Disease biospace
April 12, 2018
Abbott today announced the initiation of a clinical trial evaluating long-term outcomes of patients who undergo stent implantation guided by high-resolution light-based imaging technology
Abbott's MitraClip Therapy Receives National Reimbursement in Japan to Treat Patients with Mitral Re biospace
March 20, 2018
Abbott today announced that the Ministry of Health, Labour and Welfare of Japan (MHLW) has granted national reimbursement for the company's MitraClip therapy to treat patients with mitral regurgitation
Abbott collaborates with YRGCARE expressbpd
January 11, 2018
Abbott has announced its partnership with Y R Gaitonde Centre for AIDS Research and Education (YRGCARE) to study the country’s viral diversity to improve accuracy of diagnostic tests.
Abbott launches insertable cardiac monitor in India expressbpd
December 20, 2017
Through ICM, physicians can remotely monitor their patients for difficult to detect cardiac arrhythmias, including irregular heartbeats
MitraClip by Abbott receives approval in Japan as first transcatheter mitral valve repair device pharmaasia
November 17, 2017
The Abbott MitraClip is a minimally invasive device to treat people in Japan with common leaky heart valve for whom surgery is too risk.
Abbott pioneered in India Market by launching liquid dosing device expressbpd
November 09, 2017
The first-of-its-kind device for liquid medicines provides accurate, hygienic and convenient dosing
A great place to do great things: Developing game-changing technology at Abbott worldpharmanews
October 23, 2017
Science has spoken: Abbott (NYSE: ABT) is, again, among the best science-based companies to work for in the world.
After roller-coaster year, Abbott moves to close Alere deal fiercebiotech
September 30, 2017
After spending a year trying to wriggle out of its deal to acquire Alere, Abbott agreed on new terms for the acquisition in April this year. Now, Abbott is slated to complete the transaction on Tuesday.
Abbott Initiates U.S. Pivotal Study of AMPLATZER Device americanpharmaceuticalreview.
September 01, 2017
Abbott has initiated a U.S. pivotal clinical study evaluating the safety and effectiveness of a modified version of its AMPLATZER device designed to correct a common congenital heart defect that occurs in approximately 80,000 pre-term infants in the U.S.

Previous page 1 2 3 4 5 6 7 Next page